Adjunctive canadian Divalproex Sodium Lowers Cholesterol Elevation with Olanzapine generic Author: Daniel E. Casey, MD, Department of Psychiatry, Oregon Health Sciences University, Portland, Oregon Cardiovascular disease is a major cause of morbidity and mortality in patients with schizophrenia. Every 1% increase in total cholesterol levels results in a 2% increase in the risk of coronary [...]
Continue reading " Psychotherapy and Psychopharmacology: Adjunctive Divalproex "
Five-Year Effects of Rivastigmine on Cognitive Performance Author: Mary Sano, MD, Professor of Medicine, Mount Sinai School of Medicine, New York, New York Alzheimer’s disease (AD) is characterized by a relentless decline in cognitive performance and in the ability to perform normal daily tasks. Untreated or placebo-treated patients with AD show an average annual deterioration [...]
Continue reading " Psychotherapy and Psychopharmacology: Five-Year Effects "
Duloxetine generic Versus Placebo in Preventing Relapse of Major Depressive Disorder Author: Michael J. Detke, MD, PhD, Indiana University School of Medicine, Indianapolis, and Medical Director for Cymbalta, Lilly Research Laboratories It has been well established for more than a decade that major depressive disorder (MDD) is characterized by several distinct stages: an acute phase [...]
Continue reading " Psychotherapy and Psychopharmacology: Duloxetine Versus Placebo "
Effects of Atomoxetine generic and Methylphenidate on Sleep in Children with Attention-Deficit/ Hyperactivity Disorder Author: R. Bart Sangal MD, Clinical Neurophysiology Services PC, Troy, Michigan Presenter: Virginia Sutton, PhD, Lilly Research Laboratories, Indianapolis, Indiana Attention-deficit/hyperactivity disorder (ADHD) affects approximately 3% to 7% of school-aged children. It is characterized by inattention and/or hyperactivity and impulsivity. The [...]
